MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin (2021)
- Authors:
- USP affiliated authors: FAZAN JÚNIOR, RUBENS - FMRP ; BRAGA, ELIANE CANDIANI ARANTES - FCFRP ; CASTRO, MICHELE MAZZARON DE - FMRP ; SILVA, PEDRO HENRIQUE LEITE DA - FCFRP ; PARENTE, JULIANA MONTENEGRO - FMRP ; MELLO, MARCELA MARIA BLASCKE DE - FMRP ; PERNOMIAN, LAENA - FMRP ; OLIVEIRA, ISADORA SOUSA DE - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1016/j.bcp.2021.114744
- Subjects: HIPERTROFIA VENTRICULAR ESQUERDA; ANTIBIÓTICOS; REGULAÇÃO GÊNICA; HIPERTENSÃO; METALOPROTEINASES
- Keywords: Cardiac hypertrophy; Matrix metalloproteinase; Troponin I; Dystrophin; Hypertension
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2021
- Source:
- Título: Biochemical Pharmacology
- ISSN: 0006-2952
- Volume/Número/Paginação/Ano: v. 193, art. 114744, p. 1-13, 2021
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PARENTE, Juliana Montenegro et al. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, v. 193, p. 1-13, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2021.114744. Acesso em: 28 dez. 2025. -
APA
Parente, J. M., Mello, M. M. B. de, Silva, P. H. L. da, Omoto, A. C. M., Pernomian, L., Oliveira, I. S. de, et al. (2021). MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin. Biochemical Pharmacology, 193, 1-13. doi:10.1016/j.bcp.2021.114744 -
NLM
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744 -
Vancouver
Parente JM, Mello MMB de, Silva PHL da, Omoto ACM, Pernomian L, Oliveira IS de, Mahmud Z, Júnior RF, Arantes EC, Schulz R, Castro MM de. MMP inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin [Internet]. Biochemical Pharmacology. 2021 ; 193 1-13.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.bcp.2021.114744 - Mmp-2 inhibition attenuates hypertensive eccentric cardiac hypertrophy and dysfunction by preserving troponin I and dystrophin
- Arterial hypertension may involve sarcoplasmic reticulum calcium atpase (serca) proteolysis by matrix metalloproteinase (mmp)-2
- The role of matrix metalloproteinase (MMP)-2 to type I collagen turnover contributing to hypertrophic arterial remodeling in renovascular hypertension
- Matrix metalloproteinase (MMP)-2 activation by oxidative stress decreases aortic calponin-1 levels during hypertrophic remodeling in early hypertension
- Sodium hydrogen sulfide improves renovascular hypertension-induced maladaptive cardiac remodeling and diastolic dysfunction by reducing oxidative stress and mmp activity
- Matrix metalloproteinase in the cardiovascular remodeling of hypertension: current insights and therapeutic potential
- Type I collagen proteolysis by matrix metalloproteinase-2 contributes to focal adhesion kinase activation and vascular smooth muscle cell proliferation in the aorta in early hypertension
- Verapamil decreases calpain-1 and matrix metalloproteinase-2 activities and improves hypertension-induced hypertrophic cardiac remodeling in rats
- Proteólise de troponina I e distrofina pela metaloproteinase de matriz (MMP)-2 contribui para a transição de hipertrofia cardíaca concêntrica para excêntrica na hipertensão renovascular crônica
- Isolamento e caracterização estrutural e funcional da lectina do veneno de sapo Rhinella schneideri
Informações sobre o DOI: 10.1016/j.bcp.2021.114744 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003086645.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
